Correction: I Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline.
Main Authors: | Yaron D. Barac, Orit Bar-Am, Esti Liani, Tamar Amit, Luba Frolov, Elena Ovcharenko, Itzchak Angel, Moussa B. H. Youdim, Ofer Binah |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3677844 |
Similar Items
-
I1 imidazoline receptor: novel potential cytoprotective target of TVP1022, the S-enantiomer of rasagiline.
by: Yaron D Barac, et al.
Published: (2012-01-01) -
Correction: I1 Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline
by: Yaron D. Barac, et al.
Published: (2013-01-01) -
Activation of tyrosine kinase receptor signaling pathway by rasagiline facilitates neurorescue and restoration of nigrostriatal dopamine neurons in post-MPTP-induced parkinsonism
by: Yotam Sagi, et al.
Published: (2007-01-01) -
Rasagiline-Induced Hypoglycemia
by: Nurhan Bilen, et al.
Published: (2016-12-01) -
Rasagiline in treatment of Parkinson’s disease
by: Lakshmi Nayak, et al.
Published: (2008-03-01)